drugset / Trial / NCT06246565
A Study of HS-10383 in Chinese Adult Subjects With Refractory or Unexplained Chronic Cough (RUCC)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-designed phase 2 clinical trial to evaluate the efficacy, safety and pharmacokinetic (PK) characteristics of HS-10383 in Chinese adult subjects with refractory or unexplained chronic cough (RUCC).
Timeline
- Start
- 2024-03-01
- Primary completion
- 2025-09-01
- Completion
- 2026-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HS-10383 | Unknown | 50 mg | Oral |
| Subject | HS-10383 | Unknown | 100 mg | Oral |
| Subject | HS-10383 | Unknown | 200 mg | Oral |
Indications
No indication recorded.